Hazlett, Burt & Watson’s Boston Scientific BSX Stock Holding History

Hazlett, Burt & Watson’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$61K	Buy	1,411 +398	+39%	+$21.6K	0.02%	434
2026 Q1	$63K	Hold	1,013	–	–	0.02%	410
2025 Q4	$98K	Buy	1,013 +247	+32%	+$24.2K	0.03%	346
2025 Q3	$75K	Buy	766 +220	+40%	+$22.8K	0.03%	363
2025 Q2	$59K	Sell	546 -250	-31%	-$25.3K	0.02%	350
2025 Q1	$80K	Sell	796 -30	-4%	-$3.02K	0.04%	296
2024 Q4	$74K	Hold	826	–	–	0.03%	310
2024 Q3	$68K	Hold	826	–	–	0.03%	315
2024 Q2	$64K	Hold	826	–	–	0.03%	302
2024 Q1	$57K	Buy	826 +160	+24%	+$10.3K	0.03%	313
2023 Q4	$38K	Buy	666 +30	+5%	+$1.6K	0.03%	343
2023 Q3	$33K	Hold	636	–	–	0.02%	352
2023 Q2	$33K	Hold	636	–	–	0.02%	354
2023 Q1	$32K	Hold	636	–	–	0.03%	334
2022 Q4	$30K	Buy	636 +230	+57%	+$9.96K	0.03%	332
2022 Q3	$16K	Hold	406	–	–	0.02%	401
2022 Q2	$15K	Buy	406 +81	+25%	+$3.3K	0.01%	409
2022 Q1	$14K	Buy	+325	New	+$14.1K	0.01%	431

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Hazlett, Burt & Watson's BSX Position: Q2 2026 in Review

Hazlett, Burt & Watson increased its Boston Scientific (BSX) stake by 39% in Q2 2026, buying an estimated $21.6K and bringing the position to 1,411 shares worth $61K. The position accounts for 0.02% of the portfolio, ranked #434.

Hazlett, Burt & Watson first reported a position in BSX in Q1 2022 and has held it in 18 quarters since. The position peaked at $98K in Q4 2025. 1,480 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Hazlett, Burt & Watson held 1,411 shares of Boston Scientific worth $61K as of Q2 2026.
Hazlett, Burt & Watson bought 398 Boston Scientific shares in Q2 2026, an estimated $21.6K.
Boston Scientific made up 0.02% of Hazlett, Burt & Watson's portfolio in Q2 2026, its #434 holding.
Hazlett, Burt & Watson first reported a position in Boston Scientific in Q1 2022 and has held it in 18 quarters since.
Hazlett, Burt & Watson's Boston Scientific position peaked at $98K in Q4 2025.
1,480 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Hazlett, Burt & Watson's 13F filing for Q2 2026, filed 30 Jul 2026.